Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC) Meeting Abstract


Authors: Autio, K. A.; Fox, J. J.; Schneider, C. W.; Schöder, H.; Humm, J.; Rathkopf, D. E.; Slovin, S. F.; Danila, D. C.; Haupt, E. C.; Larson, S. M.; Scher, H. I.; Morris, M. J.
Abstract Title: Evaluating 18F-16B-fluoro-5α-dihydrotestosterone (FDHT) and FDG-PET as a measure of disease progression in metastatic castration resistant prostate cancer (mCRPC)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419602013
PROVIDER: wos
Notes: Meeting Abstract: 5090 -- Source: Wos
MSK Authors
  1. Josef J Fox
    44 Fox
  2. Susan Slovin
    184 Slovin
  3. Michael Morris
    274 Morris
  4. Karen Anne Autio
    42 Autio
  5. Heiko Schoder
    285 Schoder
  6. Dana Elizabeth Rathkopf
    142 Rathkopf
  7. John Laurence Humm
    339 Humm
  8. Steven M Larson
    766 Larson
  9. Howard Scher
    818 Scher
  10. Daniel C Danila
    82 Danila
  11. Eric C Haupt
    5 Haupt